BAJAJ BROKING
Apollo Hospitals Enterprise Ltd plans to invest ₹250 crore in India’s first Proteus One proton therapy system in Hyderabad. The facility, set to be operational by FY2028, will increase annual cancer treatment capacity by 350 patients. The investment is funded through internal accruals.
Apollo Hospitals Enterprise Ltd has announced a significant investment of ₹250 crore to establish India’s first Proteus One proton therapy system in Hyderabad. The advanced oncology centre will expand the hospital chain’s existing proton therapy capabilities and is expected to become operational by FY2028. The investment, fully funded through internal accruals, aims to enhance cancer treatment accessibility in India.
Also read: Dr Reddy’s Sells 14-Drug Portfolio to Senores Pharma for US Market Growth
Investment Amount: ₹250 crore
Facility Location: Hyderabad
Expected Operational Year: FY2028
Annual Treatment Capacity: 350 additional patients
Existing Chennai Proton Centre Capacity: 850 patients per year
Technology Partner: Ion Beam Applications (IBA)
Also read: Welspun Specialty Wins ₹231.77 Crore BHEL Contract for Boiler Tubes
Apollo Hospitals currently operates a proton therapy centre in Chennai, which treats over 500 cancer patients annually. The Chennai facility, designed for a capacity of 850 patients, was South Asia’s first proton therapy centre when launched in 2019. The new Hyderabad centre will add to this capacity, allowing an additional 350 patients to receive cutting-edge cancer treatment each year.
The Proteus One system, developed by Ion Beam Applications (IBA), is a state-of-the-art single-room proton therapy solution known for its precision and efficiency in targeting tumours. Proton therapy is widely recognised for its benefits in treating complex cancers, including central nervous system tumours, paediatric cancers, and head and neck malignancies.
Project Details | Information |
Investment Amount | ₹250 crore |
Location | Hyderabad |
Expected Completion | FY2028 |
Technology Provider | Ion Beam Applications (IBA) |
New Treatment Capacity | 350 additional patients/year |
Current Chennai Centre Capacity | 850 patients/year |
Following the announcement, Apollo Hospitals Enterprise Ltd share price closed at ₹6,183.45, reflecting a marginal gain of ₹6.30 or 0.10% on the BSE. Investors are closely monitoring the impact of this expansion on the company’s long-term growth in the healthcare sector.
Apollo Hospitals Enterprise Ltd continues to strengthen its position as a leader in cancer care by introducing advanced treatment solutions in India. The ₹250 crore investment in Hyderabad’s Proteus One system highlights its commitment to expanding proton therapy, improving patient outcomes, and enhancing its oncology infrastructure. With the project set to be completed by FY2028, Apollo Hospitals is poised to redefine cancer treatment accessibility in the country.
Also read: Power Grid Wins Bids for 3 Interstate Transmission Projects Under BOOT Model
Do you have a trading account app or demat account app?
You can open an account with Bajaj Broking in minutes.
Download the Bajaj Broking app now from Play Store or App Store.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer
Share this article:
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading